Produced by Araxis Merge on 2/19/2018 2:07:56 PM Eastern Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_035_ Manage dosage forms for pain use of buprenorphine-containing products.docx | Mon Jan 8 17:12:32 2018 UTC |
| 2 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_035_ Manage dosage forms for pain use of buprenorphine-containing products.docx | Mon Feb 19 18:07:41 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 4 | 864 |
| Changed | 3 | 7 |
| Inserted | 0 | 0 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | Department of Vetera ns Affairs | ||
| 2 | |||
| 3 | Clinical A ncillary S ervices (C AS) | ||
| 4 | |||
| 5 | |||
| 6 | Build 2 | ||
| 7 | Sprint-3 | ||
| 8 | Test Case CAS_TC_035 | ||
| 9 | |||
| 10 | CLIN# 0004 AE | ||
| 11 | December 2 017 | ||
| 12 | Version 1. 0 | ||
| 13 | Revision H istory | ||
| 14 | Date | ||
| 15 | Version | ||
| 16 | Descriptio n | ||
| 17 | Author | ||
| 18 | 08/04/2017 | ||
| 19 | 1.0 | ||
| 20 | Initial dr aft | ||
| 21 | Joseph A. McGovern | ||
| 22 | Template R evision Hi story | ||
| 23 | Date | ||
| 24 | Version | ||
| 25 | Descriptio n | ||
| 26 | Author | ||
| 27 | 08/04/2017 | ||
| 28 | 1.0 | ||
| 29 | Constructe d for CAS based on h istorical Test Case format use d on prior VA Projec ts | ||
| 30 | Joseph A. McGovern | ||
| 31 | |||
| 32 | |||
| 33 | Table of C ontents | ||
| 34 | 1Product D escription 1 | ||
| 35 | 1.1Purpose 1 | ||
| 36 | 1.2Scope1 | ||
| 37 | 2Test Case | ||
| 38 | Appendix A .Acronyms & Abbrevia tions9 | ||
| 39 | |||
| 40 | |||
| 41 | Product De scription | ||
| 42 | OneVA Phar macy Clin ical Ancil lary Servi ces (CAS) project | ||
| 43 | Purpose | ||
| 44 | The purpos e of this document i s to devel op test ca se scenari os to iden tify, clar ify, and o rganize CA S applicat ion requir ements. Th e test cas e is made up of a se t of possi ble sequen ces of int eractions between sy stems and users in t he CHYSHR and DAYTSH R environm ents to va lidate and verify th at As a VA Pharmacy Systems Ma nager, I n eed the ab ility to m anage (add , delete) buprenorph ine-contai ning medic ation dosa ge forms a pproved fo r the trea tment of p ain by the Federal D rug Admini stration ( FDA) so th at provide rs without a Detox n umber can prescribe these medi cations wi thout bein g stopped by CPRS an d Pharmacy Data Mana gement. | ||
| 45 | The CHYSHR environme nt is the Host site. The DAYT SHR enviro nment is t he dispens ing site ( remote). | ||
| 46 | The test c ase should contain a ll system activities that have significa nce to the Pharmacis t users. | ||
| 47 | Scope | ||
| 48 | As a VA Ph armacy Sys tems Manag er, I need the abili ty to mana ge (add, d elete) bup renorphine -containin g medicati on dosage forms appr oved for t he treatme nt of pain by the Fe deral Drug Administr ation (FDA ) so that providers without a Detox numb er can pre scribe the se medicat ions witho ut being s topped by CPRS and P harmacy Da ta Managem ent. | ||
| 49 | Test Case | ||
| 50 | CAS Test C ases and s upporting test scrip ts will be recorded managed in VA Enterp rise Jazz Rational Q uality Man ager Tool PBM(QM). Stakeholde rs can als o provide inputs abo ut the cur rent set o f test cas es as well as sugges t some mor e missing test cases . | ||
| 51 | This test case will: | ||
| 52 | Capture an d communic ate functi onal requi rements fo r software developme nt; and | ||
| 53 | Provide a set of tes t inputs, execution conditions , and expe cted resul ts develop ed for a p articular objective, such as t o exercise a particu lar progra m path or to verify compliance with a sp ecific req uirement o r defect r emediation . | ||
| 54 | As a VA Ph armacy Sys tems Manag er, abilit y to manag e (add, de lete) bupr enorphine- containing medicatio n dosage f orms appro ved for th e treatmen t of pain by the Fed eral Drug Administra tion (FDA) so that p roviders w ithout a D etox numbe r can pres cribe thes e medicati ons withou t being st opped by C PRS and Ph armacy Dat a Manageme nt | ||
| 55 | Field | ||
| 56 | Descriptio n | ||
| 57 | Test Case ID: | ||
| 58 | CAS_MPDU_T C_035_ Man age dosage forms for pain use of bupreno rphine-con taining pr oducts | ||
| 59 | RTC ID: | ||
| 60 | 616039 | ||
| 61 | RM ID: | ||
| 62 | 943370 | ||
| 63 | QM ID: | ||
| 64 | 167732 | ||
| 65 | Tester: | ||
| 66 | Samatha Gi rla | ||
| 67 | Environmen t: | ||
| 68 | DAYTSHR | ||
| 69 | Build : | ||
| 70 | PSD_3_83_2 0171218A.K ID,PSO_7_5 05_2017121 9A.KID,PSS _1_219_201 71204B.KID ,XU_8_689_ 20171124B. KID | ||
| 71 | Use Case N ame: | ||
| 72 | Management of provid er logical access co ntrols to EPCS | ||
| 73 | Scenario: | ||
| 74 | As a VA Ph armacy Sys tems Manag er, I need the abili ty to mana ge (add, d elete) bup renorphine -containin g medicati on dosage forms appr oved for t he treatme nt of pain by the Fe deral Drug Administr ation (FDA ) so that providers without a Detox numb er can pre scribe the se medicat ions witho ut being s topped by CPRS and P harmacy Da ta Managem ent. | ||
| 75 | Actors: | ||
| 76 | Pharmacist | ||
| 77 | Pre-Condit ion: | ||
| 78 | The Pharma cist must have an ac tive VistA account w ith access to the On eVA Pharma cy Program . | ||
| 79 | PSNMGR key should be on. | ||
| 80 | |||
| 81 | |||
| 82 | Post-Condi tion | ||
| 83 | Upon entry of valid access and verify co des on Out Patient Ph armacy Pre scription Processing system wi ll provide ability t o manage ( add, delet e) bupreno rphine-con taining me dication d osage form s approved for the t reatment o f pain by the Federa l Drug Adm inistratio n (FDA) so that prov iders with out a Deto x number c an prescri be these m edications without b eing stopp ed by CPRS and Pharm acy Data M anagement. | ||
| 84 | |||
| 85 | Steps | ||
| 86 | |||
| 87 | Pass | ||
| 88 | Fail | ||
| 89 | |||
| 90 | Actions | ||
| 91 | Pass | ||
| 92 | |||
| 93 | |||
| 94 | Log into y our local vista inst ance. | ||
| 95 | |||
| 96 | |||
| 97 | |||
| 98 | Expected R esults | ||
| 99 | |||
| 100 | |||
| 101 | |||
| 102 | User will be taken t o the acce ss/verify code promp ts. | ||
| 103 | |||
| 104 | |||
| 105 | |||
| 106 | Actions | ||
| 107 | Pass | ||
| 108 | |||
| 109 | |||
| 110 | Enter your access/ve rify code( s). | ||
| 111 | |||
| 112 | |||
| 113 | |||
| 114 | Expected R esults | ||
| 115 | |||
| 116 | |||
| 117 | |||
| 118 | User it ta ken to the default m enu prompt . | ||
| 119 | |||
| 120 | |||
| 121 | |||
| 122 | Actions | ||
| 123 | Pass | ||
| 124 | |||
| 125 | |||
| 126 | When promp ted ‘ISPA0 4:DAYTSHR> ’ D ^XUP | ||
| 127 | :”, press <return> | ||
| 128 | |||
| 129 | |||
| 130 | |||
| 131 | Expected R esults | ||
| 132 | |||
| 133 | |||
| 134 | |||
| 135 | User is ta ken to the next prom pt. | ||
| 136 | |||
| 137 | |||
| 138 | |||
| 139 | Actions | ||
| 140 | Pass | ||
| 141 | |||
| 142 | |||
| 143 | Select OPT ION NAME: PSS DOSAGE S MANAGEME NT and pre ss<Return> | ||
| 144 | |||
| 145 | |||
| 146 | |||
| 147 | Expected R esults | ||
| 148 | |||
| 149 | |||
| 150 | |||
| 151 | Dosage For m File Ent er/Edit | ||
| 152 | Enter/Edit Dosages | ||
| 153 | Most Commo n Dosages Report | ||
| 154 | Noun/Dosag e Form Rep ort | ||
| 155 | Review Dos ages Repor t | ||
| 156 | Local Poss ible Dosag es Report | ||
| 157 | Request Ch ange to Do se Unit | ||
| 158 | Lookup Dos ing Check Info for D rug | ||
| 159 | Drug Names with Trai ling Space s Report | ||
| 160 | Manage Bup renorphine Tx of Pai n Dosage F orms | ||
| 161 | |||
| 162 | |||
| 163 | You have P ENDING ALE RTS | ||
| 164 | Enter "VA to jump t o VIEW ALE RTS option | ||
| 165 | |||
| 166 | Select Dos ages <TEST ACCOUNT> Option: | ||
| 167 | |||
| 168 | |||
| 169 | |||
| 170 | Actions | ||
| 171 | Pass | ||
| 172 | |||
| 173 | |||
| 174 | Select ‘ma nage Bupre norphine T x of Pain Dosage For ms’ and pr ess <Retur n> | ||
| 175 | |||
| 176 | |||
| 177 | |||
| 178 | Expected R esults | ||
| 179 | |||
| 180 | |||
| 181 | |||
| 182 | Dosage For ms Bupreno rphine Tx of Pain ma y be set f or the fol lowing: | ||
| 183 | |||
| 184 | 5 System SYS [
|
||
| 185 | 10 P ackage PKG [PHARMACY DATA MANAG EMENT] | ||
| 186 | |||
| 187 | Enter sele ction: 5 System
|
||
| 188 | |||
| 189 | Setting D osage Form s Buprenor phine Tx o f Pain for System :
|
||
| 190 | Select Seq uence: | ||
| 191 | |||
| 192 | |||
| 193 | |||
| 194 | Actions | ||
| 195 | Pass | ||
| 196 | |||
| 197 | |||
| 198 | Select Seq uence: 1 a nd press < Return> | ||
| 199 | |||
| 200 | |||
| 201 | |||
| 202 | Expected R esults | ||
| 203 | |||
| 204 | |||
| 205 | |||
| 206 | Are you ad ding 1 as a new Sequ ence? Yes/ / | ||
| 207 | |||
| 208 | |||
| 209 | 7. | ||
| 210 | Actions | ||
| 211 | Pass | ||
| 212 | |||
| 213 | |||
| 214 | Press <Ret urn> | ||
| 215 | |||
| 216 | |||
| 217 | |||
| 218 | Expected R esults | ||
| 219 | |||
| 220 | |||
| 221 | |||
| 222 | Dosage For m: | ||
| 223 | |||
| 224 | |||
| 225 | 8. | ||
| 226 | Actions | ||
| 227 | Pass | ||
| 228 | |||
| 229 | |||
| 230 | Enter ‘Pat ch’ and pr ess <Retur n> | ||
| 231 | |||
| 232 | |||
| 233 | |||
| 234 | Expected R esults | ||
| 235 | |||
| 236 | |||
| 237 | |||
| 238 | 1 PAT CH | ||
| 239 | 2 P ATCH,BUCCA L | ||
| 240 | CHOOSE 1-2 : | ||
| 241 | |||
| 242 | |||
| 243 | 9. | ||
| 244 | Actions | ||
| 245 | Pass | ||
| 246 | |||
| 247 | |||
| 248 | Select ‘1’ and press Return | ||
| 249 | |||
| 250 | |||
| 251 | |||
| 252 | Expected R esults | ||
| 253 | |||
| 254 | |||
| 255 | |||
| 256 | Select Seq uence: | ||
| 257 | |||
| 258 | |||
| 259 | 10. | ||
| 260 | Actions | ||
| 261 | Pass | ||
| 262 | |||
| 263 | |||
| 264 | Type ‘?’ a nd press R eturn | ||
| 265 | |||
| 266 | |||
| 267 | |||
| 268 | Expected R esults | ||
| 269 | |||
| 270 | |||
| 271 | |||
| 272 | |||
| 273 | Sequence Value | ||
| 274 | -------- ----- | ||
| 275 | PATCH | ||
| 276 | Select Seq uence: | ||
| 277 | |||
| 278 | |||
| 279 | 11. | ||
| 280 | Actions | ||
| 281 | Pass | ||
| 282 | |||
| 283 | |||
| 284 | Type 2 and press <re turn> | ||
| 285 | |||
| 286 | |||
| 287 | |||
| 288 | Expected R esults | ||
| 289 | |||
| 290 | |||
| 291 | |||
| 292 | Are you ad ding 2 as a new Sequ ence? Yes/ / | ||
| 293 | |||
| 294 | |||
| 295 | 12 | ||
| 296 | Actions | ||
| 297 | Pass | ||
| 298 | |||
| 299 | |||
| 300 | Press <Ret urn> | ||
| 301 | |||
| 302 | |||
| 303 | |||
| 304 | Expected R esults | ||
| 305 | |||
| 306 | |||
| 307 | |||
| 308 | Sequence: 2// | ||
| 309 | |||
| 310 | |||
| 311 | 13 | ||
| 312 | Actions | ||
| 313 | Pass | ||
| 314 | |||
| 315 | |||
| 316 | Press <Ret urn> | ||
| 317 | |||
| 318 | |||
| 319 | |||
| 320 | Expected R esults | ||
| 321 | |||
| 322 | |||
| 323 | |||
| 324 | Dosage For m: | ||
| 325 | |||
| 326 | |||
| 327 | 14 | ||
| 328 | Actions | ||
| 329 | Pass | ||
| 330 | |||
| 331 | |||
| 332 | Type ‘TAB’ and press <return> | ||
| 333 | |||
| 334 | |||
| 335 | |||
| 336 | Expected R esults | ||
| 337 | |||
| 338 | |||
| 339 | |||
| 340 | Dosage For m: TAB | ||
| 341 | 1 T AB | ||
| 342 | 2 T AB (DELAYE D RELEASE) | ||
| 343 | 3 T AB,BUCC,SA | ||
| 344 | 4 T AB,BUCCAL | ||
| 345 | 5 T AB,CHEWABL E | ||
| 346 | Press <Ent er> to see more, '^' to exit t his list, OR | ||
| 347 | CHOOSE 1-5 : | ||
| 348 | |||
| 349 | |||
| 350 | 15 | ||
| 351 | Actions | ||
| 352 | Pass | ||
| 353 | |||
| 354 | |||
| 355 | Select ‘1’ and press return | ||
| 356 | |||
| 357 | |||
| 358 | |||
| 359 | Expected R esults | ||
| 360 | |||
| 361 | |||
| 362 | |||
| 363 | Select Seq uence: | ||
| 364 | |||
| 365 | |||
| 366 | 16 | ||
| 367 | Actions | ||
| 368 | Pass | ||
| 369 | |||
| 370 | |||
| 371 | Type ‘?’ P ress <Retu rn> | ||
| 372 | |||
| 373 | |||
| 374 | |||
| 375 | Expected R esults | ||
| 376 | |||
| 377 | |||
| 378 | |||
| 379 | Sequence Value | ||
| 380 | -------- ----- | ||
| 381 | 1 PATCH | ||
| 382 | 2 TAB | ||
| 383 | Select Seq uence: | ||
| 384 | |||
| 385 | |||
| 386 | 17 | ||
| 387 | Actions | ||
| 388 | Pass | ||
| 389 | |||
| 390 | |||
| 391 | Select ‘1’ and press return | ||
| 392 | |||
| 393 | |||
| 394 | |||
| 395 | Expected R esults | ||
| 396 | |||
| 397 | |||
| 398 | |||
| 399 | Sequence: 1// | ||
| 400 | |||
| 401 | |||
| 402 | 18. | ||
| 403 | Actions | ||
| 404 | Pass | ||
| 405 | |||
| 406 | |||
| 407 | Sequence: 1// @ and press Retu rn | ||
| 408 | |||
| 409 | |||
| 410 | |||
| 411 | Expected R esults | ||
| 412 | |||
| 413 | |||
| 414 | |||
| 415 | User able to delete the dosage form | ||
| 416 | |||
| 417 | Sequence: 1// @ ... deleted | ||
| 418 | Select Seq uence: | ||
| 419 | |||
| 420 | |||
| 421 | Acronyms & Abbreviat ions | ||
| 422 | Acronym | ||
| 423 | Definition | ||
| 424 | CAS | ||
| 425 | Clinical A ncillary S ervices | ||
| 426 | CHYSHR | ||
| 427 | Test Envir onment fo r Host sit e | ||
| 428 | CPRS | ||
| 429 | Computeriz ed Patient Record Sy stem | ||
| 430 | DAYTSHR | ||
| 431 | Test Envir onment fo r the disp ensing sit e (remote) | ||
| 432 | VHA | ||
| 433 | Veteran’s Health Adm inistratio n | ||
| 434 | VistA | ||
| 435 | Veterans H ealth Info rmation Sy stems and Technology Architect ure |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.